The European Union's medicines regulator says unusual blood clots should be listed as a very rare side effect of the Oxford-AstraZeneca COVID-19 vaccine.
After a study looking at 86 European cases, the European Medicines Agency concluded the benefits of the vaccine outweighed the risk.
The report reflected data on 25 million Europeans administered with the Oxford-AstraZeneca vaccine.
The World Health Organisation's advisory vaccine safety panel has also said the cases were "very rare" among 200 million people vaccinated with the Oxford-AstraZeneca vaccine globally.
According to Johns Hopkins University research, more than 132 million COVID-19 infections have been recorded across the world along with more than 2.8 million deaths.
[Source: BBC]
